1. Introduction {#sec1-nutrients-09-01047}
===============

In a recent report entitled "Protein Ingredients Market by Source (Animal and Plant), Application (Food & Beverage, Animal Feed, Cosmetics & Personal Care and Pharmaceuticals), and Region---Forecast to 2022", the market for protein ingredients was projected to reach 58.49 billion dollars by 2022 (i.e., compound annual growth rate of 6.0% from 2017). Indeed, Olympic as well as college athletes and many people exercising in gyms regularly use supplements with amino acids representing 10--20% of these nutritional strategies \[[@B1-nutrients-09-01047],[@B2-nutrients-09-01047],[@B3-nutrients-09-01047],[@B4-nutrients-09-01047]\]. Branched chain amino acids (BCAAs)---i.e., leucine, isoleucine and valine---account for almost 50% of the essential amino acids in food and 35% of the total content of essential amino acids in muscle proteins \[[@B5-nutrients-09-01047],[@B6-nutrients-09-01047]\].

BCAAs are important precursors of tricarboxylic acid (TCA) cycle intermediates via acetyl-CoA and Succinyl-CoA \[[@B7-nutrients-09-01047]\] and can be involved in energy production through the modulation of exercise-induced serum BCAAs oxidation \[[@B8-nutrients-09-01047]\]. In addition to their involvement as constitutive elements of the structural and contractile proteins synthesis \[[@B9-nutrients-09-01047]\], BCAAs are also considered signaling molecules \[[@B10-nutrients-09-01047]\]. Indeed, BCAAs and especially leucine have been reported to activate the mammalian target of rapamycin signaling pathway \[[@B11-nutrients-09-01047],[@B12-nutrients-09-01047]\], thereby promoting muscle-protein synthesis \[[@B13-nutrients-09-01047],[@B14-nutrients-09-01047],[@B15-nutrients-09-01047]\]. It has also been suggested that they could enhance mitochondrial biogenesis and reactive oxygen species scavenging \[[@B7-nutrients-09-01047],[@B16-nutrients-09-01047]\] leading to potential benefits in skeletal muscle energy metabolism \[[@B17-nutrients-09-01047],[@B18-nutrients-09-01047],[@B19-nutrients-09-01047]\].

Taking into account all the physiological mechanisms linked to BCAAs intake and that BCAAs are mainly metabolized in skeletal muscle \[[@B5-nutrients-09-01047]\], whereas other essential amino acids are catabolized in liver \[[@B20-nutrients-09-01047]\]; BCAAs supplementation has been considered as a potential nutritional strategy to avoid or at least alleviate exercise-induced muscle damage or its consequences. Exercise-induced muscle damage (EIMD) has been primarily associated with mechanical strain \[[@B21-nutrients-09-01047],[@B22-nutrients-09-01047]\] and the subsequent inflammation processes \[[@B23-nutrients-09-01047]\]. On that basis, it has been considered that diminished muscle-protein breakdown during exercise \[[@B24-nutrients-09-01047]\] and the scavenging of reactive oxygen species \[[@B7-nutrients-09-01047]\] could alleviate structural and metabolic alterations observed after EIMD \[[@B25-nutrients-09-01047],[@B26-nutrients-09-01047]\]. In addition, the anabolic effect associated with BCAAs consumption and especially leucine \[[@B9-nutrients-09-01047],[@B27-nutrients-09-01047]\] has been considered a potential promoter of the repair process of altered muscle tissues in part composed of proteins. However, so far, no imaging study has ever reported direct evidence supporting these assumptions (e.g., \[[@B28-nutrients-09-01047]\]). Therefore, the occurrence of muscle damage in all studies considered in this systematic review was assessed on the basis of EIMD outcomes, including muscle function alteration (i.e., force loss), increased blood markers of muscle damage (i.e., creatine kinase (CK), lactate dehydrogenase (LDH) and myoglobin) and delayed onset muscle soreness.

The aim of this systematic review was to objectively describe the effects of BCAAs supplementation on indirect markers of muscle damage considering studies reporting clinical trials (cross-over design and randomized clinical trials with a control group) involving healthy subjects supplemented with BCAAs only. Potential confounding factors were determined relating to the extent of muscle damage (i.e., low, moderate and high) and the supplementation strategy (i.e., duration, frequency and amount).

This systematic review provides a comprehensive analysis of the literature regarding the assumption that BCAAs supplementation can alleviate alterations of skeletal muscle function acting on exercise-induced muscle damage or muscle injury. Recommendations on the most efficient nutritional strategy to minimize consequences of damage induced by exercise on muscle function are highlighted.

2. Methods {#sec2-nutrients-09-01047}
==========

The pre-defined review protocol was registered prospectively with Prospective Register for Systematic Reviews (PROSPERO---registration number: CRD42017073006). This systematic review was completed in accordance with the recommendations of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines \[[@B29-nutrients-09-01047]\].

2.1. Eligibility Criteria {#sec2dot1-nutrients-09-01047}
-------------------------

Criteria for study inclusion were chosen using the Population-Intervention-Comparator-Outcomes-Study design (PICOS) format \[[@B29-nutrients-09-01047]\]. Articles and studies were included if they met all the following criteria: (1) experiments performed in humans; (2) healthy subjects received at least one oral BCAAs supplementation as a nutritional strategy in the context of skeletal muscle damage (i.e., decrease in muscle performance and/or increase in plasma/serum intracellular component concentration); (3) supplementation only composed of leucine, isoleucine and valine; (4) follow up performed at least one day after exercise-induced muscle damage or muscle injury; (5) original research articles; and (6) written in English. Studies were excluded if the experimental group(s) undertook any other practice that could be perceived as a strategy to alleviate muscle damage (e.g., massage, cryotherapy). Outcome measures were changes in indirect markers of muscle damage, i.e., muscle function performance (isometric force, jump height) and plasma/serum concentration of intracellular components (creatine kinase, lactate dehydrogenase, myoglobin). Clinical trials using a control group or a cross over design were included in the systematic review.

2.2. Search Strategy {#sec2dot2-nutrients-09-01047}
--------------------

The computerized literature search was performed from date of commencement until August 2017 using four online databases: Medline (PubMed), Cochrane library, Web of Science and ScienceDirect; a supplementary Google Scholar search was also undertaken. The key words used to find relevant papers were: ("muscle damage" OR "muscle injury" OR "exercise-induced muscle damage" OR EIMD) AND ("nutritional strategy" OR "branched-chain amino acid" OR BCAA OR supplementation). The reference sections of all identified articles were also examined.

2.3. Data Extraction and Quality Assessment {#sec2dot3-nutrients-09-01047}
-------------------------------------------

Data related to participants (sex, sample size, age), experimental design (randomization, blinding, wash-out period in case of cross-over design, dietary control), exercise (intensity, volume and type of exercise), outcome measures (muscle performance and blood analyses) and supplementation strategy (duration, frequency, daily intake of BCAAs, relative concentration of leucine/isoleucine/valine) were extracted. The quality of selected studies (i.e., corresponding to all eligibility criteria) were rated using the Quality Criteria Checklist for Primary Research \[[@B30-nutrients-09-01047]\] to limit the risk of bias. Significant and non-significant results were also exhaustively reported to objectively assess effects of each supplementation strategy (combining duration, frequency and amount of daily BCAAs intake) on the extent of muscle damage.

3. Analysis {#sec3-nutrients-09-01047}
===========

A greater emphasis was placed on findings from studies achieving high-quality ratings. Significant effects described in the included studies were extracted to quantify outcomes associated with the damaging exercise and the BCAAs supplementation. Rating criteria were created according to the supplementation strategy and the extent of muscle damage ([Table 1](#nutrients-09-01047-t001){ref-type="table"}). Due to the heterogeneity of the study designs, interventions and outcomes, a meta-analysis was not undertaken.

4. Results {#sec4-nutrients-09-01047}
==========

We initially identified two thousand one hundred and thirty-three papers from databases and internet searches and included 11 studies in the present systematic review according to the 4-phase flow diagram described in [Figure 1](#nutrients-09-01047-f001){ref-type="fig"}.

The included studies were trials with numbers of subjects ranging from 9 to 30 and were conducted in the last 20 years ([Table 2](#nutrients-09-01047-t002){ref-type="table"}). We identified large heterogeneity regarding supplementation strategies and damaging exercise modalities leading to a large variability in the damage extents.

4.1. Study Quality {#sec4dot1-nutrients-09-01047}
------------------

The majority of studies included in the systematic review were rated as positive (55%). Neutral (27%) and negative (18%) qualities were reported for the other studies ([Table 3](#nutrients-09-01047-t003){ref-type="table"}) for multiple reasons including a cross-over design without a control group \[[@B33-nutrients-09-01047],[@B34-nutrients-09-01047],[@B38-nutrients-09-01047],[@B40-nutrients-09-01047]\], the lack of efficient randomization and blinding \[[@B31-nutrients-09-01047],[@B33-nutrients-09-01047],[@B34-nutrients-09-01047],[@B36-nutrients-09-01047],[@B37-nutrients-09-01047],[@B40-nutrients-09-01047]\] and the absence of statements on funding and sponsorship \[[@B31-nutrients-09-01047],[@B34-nutrients-09-01047],[@B38-nutrients-09-01047],[@B40-nutrients-09-01047]\]. In addition, short follow-up of exercise-induced muscle damage outcomes (\<2 days) was also observed in studies rated as negative \[[@B33-nutrients-09-01047],[@B38-nutrients-09-01047]\].

Moreover, the supplementation strategy and the extent of EIMD were considered as cofounding parameters to objectively assess the effects of BCAAs on muscle damage outcomes.

4.2. Supplementation Strategy and Muscle Damage Extent {#sec4dot2-nutrients-09-01047}
------------------------------------------------------

Duration, frequency and daily amount of BCAAs was rated ([Table 4](#nutrients-09-01047-t004){ref-type="table"}). More than half of the studies reported a short (≤3 days) duration of supplementation whereas the frequency and the daily amount of BCAAs intakes (from low to high) was similarly distributed among the included studies.

The damage extent was generally low in the included studies. It is noteworthy that a few studies reported discordant changes in muscle performance and CK/LDH measurements \[[@B36-nutrients-09-01047],[@B40-nutrients-09-01047]\] as a result of EIMD (i.e., large decrease in force and no/small change in plasma CK).

4.3. Outcomes {#sec4dot3-nutrients-09-01047}
-------------

The positive effects of BCAAs supplementation on EIMD outcomes are reported in [Table 5](#nutrients-09-01047-t005){ref-type="table"}. The number of studies demonstrating a positive effect was equivalent to the number of studies which showed no effect. It should be noted that a positive effect was clearly reported by the lower quality studies whereas positive quality studies described no significant effect except for the results from Howatson et al. \[[@B35-nutrients-09-01047]\].

Considering the studies with positive and neutral quality rating, the benefits of BCAAs supplementation was mostly observed when the supplementation strategy included a high amount of BCAAs intake (\>200 mg kg^−1^ day^−1^) in a context of low-to-moderate muscle damage extent \[[@B31-nutrients-09-01047],[@B33-nutrients-09-01047],[@B35-nutrients-09-01047],[@B38-nutrients-09-01047]\]. In addition, a high frequency of BCAAs intake (2 or more daily intakes) and a long duration of supplementation (\>10 days) and even more on several days before the damaging exercise (at least 7 days prior to the damaging exercise in the two studies showing a positive effect of BCAAs supplementation) appears to alleviate outcomes of EIMD \[[@B31-nutrients-09-01047],[@B35-nutrients-09-01047]\].

5. Discussion {#sec5-nutrients-09-01047}
=============

In the last few years, nutritional strategy has been considered crucial for the optimization of muscle performance. More particularly, BCAAs supplementation has been used in the field of sports with the aims of limiting the outcomes (e.g., force loss) of EIMD. Throughout this systematic review, we identified that BCAAs can alleviate outcomes of EIMD for specific conditions regarding the extent of muscle damage and the supplementation strategy. Potential benefits of BCAAs supplementation can actually be obtained for low-to-moderate extent of muscle damage and considering a supplementation strategy that includes high daily BCAAs intake over a long period of time (i.e., several days) and especially before the damaging exercise period.

Previous systematic reviews have reported positive chronic effects of protein supplementation on muscle mass, strength and power \[[@B42-nutrients-09-01047]\]. The corresponding physiological mechanisms---i.e., a decreased muscle-protein breakdown \[[@B24-nutrients-09-01047]\] and a reactive oxygen species scavenging \[[@B7-nutrients-09-01047]\]---could also lead to improved muscle performance and be beneficial in alleviating muscle damage. However, the efficiency of the latter mechanisms could require time thereby explaining the potential need for long-lasting supplementation prior to EIMD in order to obtain potential benefits.

5.1. Extent of Exercise-Induced Muscle Damage {#sec5dot1-nutrients-09-01047}
---------------------------------------------

A first confounding factor for the assessment of BCAAs supplementation was the extent of muscle tissue alteration reported in the included studies. These alterations and the corresponding extent were estimated and rated from changes in indirect markers of muscle damage including decreased muscle performance and increased amount of blood markers (i.e., plasma/serum CK, LDH and/or myoglobin). As reported previously, the maximal voluntary contraction (MVC) loss is currently considered as the most reliable indicator of muscle injury \[[@B43-nutrients-09-01047]\] as compared to CK measurements. Indeed, a high inter-subject variability was found in plasma/serum CK level changes resulting from EIMD \[[@B25-nutrients-09-01047],[@B36-nutrients-09-01047]\]. In "high-responder" subjects---i.e., those with the higher CK levels---the increased plasma/serum CK levels were then uncorrelated to the extent of muscle damage \[[@B21-nutrients-09-01047],[@B44-nutrients-09-01047]\]. However, despite the variability of this outcome, it remains moderately correlated to muscle alterations assessed with MRI \[[@B45-nutrients-09-01047]\]. Therefore, we considered in the present systematic review that the combination of changes in force and blood markers both led to an objective assessment of muscle damage extent.

Muscle soreness is a subjective outcome of EIMD \[[@B46-nutrients-09-01047],[@B47-nutrients-09-01047]\] given that it is strongly related to the subject's previous experience with muscle damage. In the papers selected in the present systematic review, soreness was quantified as an outcome of EIMD in order to detect onset of muscle damage \[[@B21-nutrients-09-01047]\] but was not taken into account to estimate the extent of the corresponding alterations \[[@B48-nutrients-09-01047]\]. A methodological limitation can also be addressed regarding the assessment of muscle damage on the basis of MVC measurements. Indeed, MVC could not be considered a reliable marker to assess muscle damage extent taking into account the peripheral and central nervous alterations demonstrated in the first days after the damaging exercise \[[@B45-nutrients-09-01047],[@B49-nutrients-09-01047],[@B50-nutrients-09-01047],[@B51-nutrients-09-01047],[@B52-nutrients-09-01047]\]. Ideally, imaging methods such as electron microscopy, MRI or ultrasound elastography could be used to visualize the extent and assess the severity of muscle damage \[[@B28-nutrients-09-01047],[@B53-nutrients-09-01047],[@B54-nutrients-09-01047]\]. Most of the studies included in this review did not use these imaging methods in order to assess muscle damage and it has been sometimes difficult to assess muscle damage extent from changes in blood markers and muscle performance.

Putting aside these methodological considerations, positive effects of BCAAs supplementation have been mainly reported for low-to-moderate muscle damage induced by exercise. For larger muscle alterations, which have been reported in two studies \[[@B32-nutrients-09-01047],[@B35-nutrients-09-01047]\], no significant effect of BCAAs supplementation has been disclosed. In these latter studies, the physiological benefits commonly linked to BCAAs supplementation---i.e., promotion of muscle-protein synthesis, reduction of protein oxidation, mitochondrial biogenesis and scavenging of reactive oxygen species---could not overcome the large alterations of muscle structural organization and/or muscle metabolism previously described \[[@B25-nutrients-09-01047],[@B26-nutrients-09-01047],[@B28-nutrients-09-01047],[@B55-nutrients-09-01047],[@B56-nutrients-09-01047]\]. However, muscle energetics impairment \[[@B57-nutrients-09-01047]\] and structural alterations \[[@B58-nutrients-09-01047],[@B59-nutrients-09-01047],[@B60-nutrients-09-01047]\] associated with low-to-moderate extent of muscle damage could be alleviated by a specific BCAAs supplementation strategy.

5.2. The Supplementation Strategy {#sec5dot2-nutrients-09-01047}
---------------------------------

In the present review, we considered three criteria (frequency, amount, duration) in order to more accurately assess the BCAAs supplementation strategies reported in the selected studies. A high frequency of BCAAs intake (i.e., two or more daily intakes per day) was used over the whole set of studies demonstrating benefits regarding EIMD. In addition, the daily amount of BCAAs and the supplementation duration seem to be important factors. Positive effects of BCAAs supplementation were mainly obtained for a high daily amount of BCAAs intake (\>200 mg kg^−1^ day^−1^) over a long period of time \[[@B31-nutrients-09-01047],[@B35-nutrients-09-01047]\]. However, the combination of these three criteria (i.e., frequency, amount and duration) appears critical to potentially trigger beneficial effects from BCAAs supplementation. For instance, considering low-to-moderate EIMD, a low frequency (i.e., less than 2 intakes per day) and a low daily amount of BCAAs intake (i.e., less than 200 mg kg^−1^ day^−1^) during a moderate supplementation duration (i.e., between 4 and 10 days) was not enough to produce benefits on EIMD indirect markers \[[@B37-nutrients-09-01047]\]. Moreover, no significant positive effects on outcomes has been found when supplementation combined a high frequency and a high daily amount over a short period of time \[[@B36-nutrients-09-01047],[@B41-nutrients-09-01047]\]. A long BCAAs supplementation period (\>10 days) appears necessary if one is expecting beneficial effects. Previous studies investigating the damaging effect of marathon on skeletal muscle used this rationale to assess the potential beneficial effects of BCAAs supplementation \[[@B61-nutrients-09-01047]\]. The authors reported no effect but did not investigate the delayed outcomes of EIMD and the study was thus excluded from the present systematic review. The inclusion/exclusion criteria we chose were relatively restrictive. In that way, several studies of interest were excluded to avoid additional confounding effects mainly associated with the composition of the supplementation mixture. A recent systematic review reported the global effects of protein supplementation \[[@B62-nutrients-09-01047]\].

Chronic BCAAs supplementation has been shown to produce positive effects in both animals and humans \[[@B7-nutrients-09-01047],[@B16-nutrients-09-01047]\]. Increased skeletal muscle mitochondrial biogenesis and prevention of oxidative damage were described as potential mechanisms contributing to the increased lifespan in animals \[[@B16-nutrients-09-01047]\]. Therefore, BCAAs supplementation taken prior (days/weeks) to damaging exercise could prevent skeletal muscle tissues alterations through the enhanced mitochondrial biogenesis and reactive oxygen species scavenging \[[@B7-nutrients-09-01047]\]. This would occur via an upregulation of peroxisome proliferator-activated receptor-γ coactivator 1α expression \[[@B7-nutrients-09-01047],[@B16-nutrients-09-01047]\].

6. Conclusions {#sec6-nutrients-09-01047}
==============

In summary, the efficacy of a nutritional strategy based on BCAAs supplementation and aimed at reducing/preventing muscle damage resulting from high-intensity exercise seems to be poor. Among the studies selected in the present review, only one rated as positive regarding the quality of reported beneficial effects \[[@B35-nutrients-09-01047]\]. However, these beneficial effects should be considered with caution given the small sample size (*n* = 6) of both the control and supplemented groups. Overall, this systematic review suggests that a BCAAs supplementation strategy with daily intake larger than 200 mg kg^−1^ day^−1^, duration longer than 10 days starting at least 7 days before the damaging exercise would be effective to limit muscle damage resulting from exercise. On that basis, one can expect a peak force loss of less than 15% and/or an increase in plasma/serum CK peaking at one day following the damaging exercise. However, further placebo-controlled randomized clinical trials would be needed to support the beneficial effects of this strategy. In addition, it might be of interest to assay the effects of other nutritional strategies for which BCAAs could be combined with taurine \[[@B39-nutrients-09-01047]\] or other essential amino acids \[[@B63-nutrients-09-01047]\] and for which potentiator effects of BCAAs have been suggested.

As a take home message, there is no direct evidence of positive effects of BCAAs on muscle damage. However, in specific conditions, BCAAs supplementation seems to diminish the outcomes of EIMD. It would be of interest to further support these findings on the basis of imaging investigations.
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nutrients-09-01047-t001_Table 1

###### 

Rating criteria concerning the supplementation strategy (i.e., duration, frequency and amount of daily BCAAs intake) and the extent of muscle damage assessed from changes in indirect markers of muscular alterations in the control group.

                                 Category                                                                                                                                                                Rating                                                                                                                                                       Criteria
  ------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------
  **Supplementation Strategy**   **Duration**                                                                                                                                                            Short                                                                                                                                                        The supplementation was performed on 3 days or less
  Moderate                       The supplementation was performed between 4 and 10 days                                                                                                                                                                                                                                                                              
  Long                           The supplementation was performed for more than 10 days                                                                                                                                                                                                                                                                              
  **Frequency**                  Low                                                                                                                                                                     Less than 2 intakes per day during the supplementation period                                                                                                
  High                           2 or more intakes per day during the supplementation period                                                                                                                                                                                                                                                                          
  **Amount**                     Low                                                                                                                                                                     Less than 200 mg kg^−1^ day^−1^ of BCAAs intake                                                                                                              
  High                           200 mg kg^−1^ day^−1^ or more of BCAAs intake                                                                                                                                                                                                                                                                                        
  **Extent of Muscle Damage**    Low                                                                                                                                                                     Low peak decrease in force (≤10% of baseline) and significant peak change in CK/LDH/myoglobin at D1 (with no significant difference in the following days)   
  Moderate                       Moderate peak decrease in force (≥10% and ≤15% of baseline) and significant peak change in CK/LDH/myoglobin at D1 (with significant difference in the following days)                                                                                                                                                                
  High                           High peak decrease in force (\>15% of baseline) and significant peak change in CK/LDH/myoglobin after D2                                                                                                                                                                                                                             

nutrients-09-01047-t002_Table 2

###### 

Studies included in the systematic review.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                       Population                                                       Study Design                   Damaging Exercise                                                            Supplementation Strategy                                                                            Outcomes                                                                                           
  ----------------------------------------------------------- ---------------------------------------------------------------- ------------------------------ ---------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ---------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------
  Coombes & McNaughton (2000) \[[@B31-nutrients-09-01047]\]   16 healthy males\                                                CG (*n* = 8)\                  Cycling ergometer exercise at 70% V̇O~2max~ for 120 min                       14 days of supplementation (7 days before and 6 days after exercise).\                              \-                                       CG \> SG at H4, D1, D3 and D5 for CK and LDH              \-
                                                              age: 21 ± 1 years\                                               Dietary control                                                                                             2 × 6 g every day + 20 g before and after the exercise\                                                                                                                                                
                                                              V̇O~2max~: 52 ± 4 mL min^−1^ kg^−1^\                                                                                                                                          Amount of BCAA: 208 g (14 days)\                                                                                                                                                                       
                                                              training status: regular physical activity                                                                                                                                   LEU/ISO/VAL (1:1:1)\                                                                                                                                                                                   
                                                                                                                                                                                                                                           Placebo: no supplementation                                                                                                                                                                            

  Fouré et al. (2016) \[[@B32-nutrients-09-01047]\]           26 healthy males\                                                RCT, DB\                       Neuromuscular Electrostimulation---40 isometric knee extensions              5 days of supplementation (2 supp before, 1 supp after exercise and 1 supp every day for 4 days)\   CG = SG                                  SG \> CG at D4 for CK                                     CG = SG for the MVC
                                                              age: 22 ± 2 years\                                               CG (*n* = 13)\                                                                                              Amount of BCAA: 48.3 g (5 days)\                                                                                                                                                                       
                                                              training status: recreationally active                           Dietary control                                                                                             LEU/ISO/VAL (2:1:1)\                                                                                                                                                                                   
                                                                                                                                                                                                                                           Placebo: microcrystalline cellulose                                                                                                                                                                    

  Gee & Deniel (2016) \[[@B33-nutrients-09-01047]\]           11 healthy males\                                                RCT, SB\                       Strength exercises (back squat, press exercises, deadlift and barbell row)   Single day supplementation (1 supp before and 1 supp after exercise)\                               CG = SG                                  \-                                                        SG \> CG at D1 for the CMJ and the SSPT
                                                              age: 25 ± 6 years\                                               Cross-over (washout: 7 days)                                                                                Amount of BCAA: 20 g (1 day)\                                                                                                                                                                          
                                                              training status: resistance-trained                                                                                                                                          LEU/ISO/VAL (2:1:1)\                                                                                                                                                                                   
                                                                                                                                                                                                                                           Placebo: apple and blackcurrant juice                                                                                                                                                                  

  Greer et al. (2007) \[[@B34-nutrients-09-01047]\]           9 healthy males\                                                 Cross-over\                    Cycling ergometer exercise at 55% V̇O~2max~ for 90 min                        Single day supplementation (1 supp before and 1 supp at 60 min during the exercise)\                CG \> SG at D1                           CG \> SG at H4, D1 and D2 for CK\                         SG \> CG at D2 for leg flexion torque (180°/s)
                                                              age: 22 ± 3 years\                                               (washout: 8 days)\                                                                                          Amount of BCAA: 5 g (1 day)\                                                                                                                 CG \> SG at H4 for LDH                                    
                                                              V̇O~2max~: 36 ± 2 mL min^−1^ kg^−1^\                              Dietary control                                                                                             LEU/ISO/VAL (2.5:1:1.5)\                                                                                                                                                                               
                                                              training status: untrained                                                                                                                                                   Placebo: water, lemon flavor, salts and artificial sweeteners.                                                                                                                                         

  Howatson et al. (2012) \[[@B35-nutrients-09-01047]\]        12 healthy males\                                                RCT, DB\                       Drop jumps (5 × 20, height: 60 cm)                                           12 days of supplementation (7 days before and 4 days after exercise).\                              CG \> SG at D1 and D2                    CG \> SG for CK\                                          SG \> CG (group effect considering the time range from D0 to D4) for the MVC
                                                              age: 23 ± 2 years\                                               CG (*n* = 6)                                                                                                2 × 10 g every day + 20 g before and after the exercise Amount of BCAA: 280 g (12 days)\                                                     (group effect considering the time range from D0 to D4)   
                                                              training status: trained in collective sports (twice per week)                                                                                                               LEU/ISO/VAL (2:1:1)\                                                                                                                                                                                   
                                                                                                                                                                                                                                           Placebo: aspartame based artificial sweeteners.                                                                                                                                                        

  Jackman et al. (2010) \[[@B36-nutrients-09-01047]\]         24 healthy males\                                                SB\                            Eccentric exercise (12 × 10 knee extensions, 120% of 1 RM)                   3 days of supplementation (1 supp before, 3 supp after exercise and 4 supp every day for 2 days)\   CG \> SG with knee flexed at D2 and D3   CG = SG for CK and myoglobin                              CG = SG
                                                              age: n/a\                                                        CG (*n* = 12)\                                                                                              Amount of BCAA: 87.6g (3 days)\                                                                                                                                                                        
                                                              training status: n/a                                             Dietary control                                                                                             LEU/ISO/VAL (2.1:1.2:1)\                                                                                                                                                                               
                                                                                                                                                                                                                                           Placebo: Artificially sweetened and flavored water                                                                                                                                                     

  Kephart et al. (2016) \[[@B37-nutrients-09-01047]\]         30 healthy males\                                                RCT\                           3 back squat exercises on three consecutive days (10 × 5 at 80% of 1 RM)     4 days of supplementation (1 supp after the exercise on the first 3 days and 1 supp on day 4)\      CG = SG                                  CG = SG for myoglobin                                     CG = SG
                                                              age: 22 ± 1 years\                                               CG (*n* = 15)\                                                                                              Amount of BCAA: 24g (4 days)\                                                                                                                                                                          
                                                              training status: resistance-trained                              Dietary control                                                                                             LEU/ISO/VAL (3:1:2) and CHO\                                                                                                                                                                           
                                                                                                                                                                                                                                           Placebo: CHO                                                                                                                                                                                           

  Matsumoto et al. (2007) \[[@B38-nutrients-09-01047]\]       12 healthy subjects (males: *n* = 6 and female: *n* = 6)\        RCT DB\                        7 sessions on 3 days of long distance runs                                   3 days of supplementation (20g/day)\                                                                CG \> SG at D1                           CG \> SG at D1 for CK, LDH and myoglobin                  \-
                                                              age: 20 ± 1 years\                                               Cross-over\                                                                                                 Amount of BCAA: 60g (3 days)\                                                                                                                                                                          
                                                              training status: trained in long distance running                (washout: 3 weeks)\                                                                                         LEU/ISO/VAL (2:1:1)\                                                                                                                                                                                   
                                                                                                                               Dietary control                                                                                             Placebo: n/a                                                                                                                                                                                           

  Ra et al. (2013) \[[@B39-nutrients-09-01047]\]              18 healthy male subjects\                                        RCT, DB\                       Eccentric exercise (6 × 5 elbow flexions, 90% of MVC)                        18 days of supplementation (14 days before and 4 days after exercise).\                             CG = SG                                  CG = SG for CK and LDH                                    \-
                                                              age: 23 ± 1 years\                                               CG (*n* = 9)                                                                                                3 × 3.2 g every day\                                                                                                                                                                                   
                                                              training status: n/a                                                                                                                                                         Amount of BCAA: 172.8g (18 days)\                                                                                                                                                                      
                                                                                                                                                                                                                                           LEU/ISO/VAL (2:1:1)\                                                                                                                                                                                   
                                                                                                                                                                                                                                           Placebo: starch                                                                                                                                                                                        

  Shimomura et al. (2010) \[[@B40-nutrients-09-01047]\]       12 healthy female subjects\                                      Cross-over\                    Resistance exercise (7 × 20 squat with body weight)                          Single day supplementation (1 supp before the exercise)\                                            CG \> SG at D2 and D3                    CG = SG for CK and myoglobin                              SG \> CG at D3 for MVC
                                                              age: 22 ± 2 years\                                               (washout: 11 weeks)                                                                                         Amount of BCAA: 5.5g (1 day)\                                                                                                                                                                          
                                                              training status: untrained                                                                                                                                                   LEU/ISO/VAL (2.3:1:1.2)\                                                                                                                                                                               
                                                                                                                                                                                                                                           Placebo: dextrin                                                                                                                                                                                       

  Waldron et al. (2017) \[[@B41-nutrients-09-01047]\]         16 healthy subjects (males: *n* = 14 and female: *n* = 2)\       RCT\                           Strength exercise (10 × 6 back squats at 70% of 1 RM)                        3 days of supplementation (1 supp before, 1 supp after exercise and 2 supp every day for 2 days)\   CG = SG                                  SG \> CG at D1 and D2 for CK                              CG = SG for MVC and CMJ
                                                              age: 22 ± 2 years\                                               CG (*n* = 8)\                                                                                               Amount of BCAA: 48g (3 days)\                                                                                                                                                                          
                                                              training status: trained in resistance exercise                  Dietary control                                                                                             LEU/ISO/VAL (2:1:1) and dextrose\                                                                                                                                                                      
                                                                                                                                                                                                                                           Placebo: dextrose                                                                                                                                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

LDH: lactate dehydrogenase; CK: creatine kinase; V̇O~2max~: maximal oxygen consumption; CG: control group; SG: supplemented group; RM: maximal repetition; H: hour (e.g., H4: four hours after the end of the damaging exercise); D: day (e.g., D4: four days after the damaging exercise); supp: supplementation; LEU: leucine; ISO: isoleucine; VAL: valine; CHO: carbohydrates; RCT: randomized clinical trial; DB: double blind; SB: single blind; MVC: maximal voluntary contraction force; CMJ: counter movement jump; SSPT: seated shot-put throw; n/a: not available.

nutrients-09-01047-t003_Table 3

###### 

Quality assessment of included studies.

  References                                                  Validity Rating   Overall Rating                                     
  ----------------------------------------------------------- ----------------- ---------------- --- --- --- --- ---- --- ---- --- ----
  Coombes & McNaughton (2000) \[[@B31-nutrients-09-01047]\]   Y                 Y                Y   N   N   Y   Y    Y   Y    N   ø
  Fouré et al. (2016) \[[@B32-nutrients-09-01047]\]           Y                 Y                Y   Y   Y   Y   Y    Y   Y    Y   \+
  Gee & Deniel (2016) \[[@B33-nutrients-09-01047]\]           Y                 Y                N   N   N   N   Y    Y   Y    Y   ø
  Greer et al. (2007) \[[@B34-nutrients-09-01047]\]           Y                 Y                N   N   N   N   Y    N   Y    N   --
  Howatson et al. (2012) \[[@B35-nutrients-09-01047]\]        Y                 Y                Y   Y   Y   Y   Y    N   Y    Y   \+
  Jackman et al. (2010) \[[@B36-nutrients-09-01047]\]         Y                 Y                Y   N   N   Y   Y    Y   Y    Y   \+
  Kephart et al. (2016) \[[@B37-nutrients-09-01047]\]         Y                 Y                Y   N   N   Y   Y    Y   Y    Y   \+
  Matsumoto et al. (2007) \[[@B38-nutrients-09-01047]\]       Y                 N                N   N   Y   Y   Y    Y   Y    N   ø
  Ra et al. (2013) \[[@B39-nutrients-09-01047]\]              Y                 Y                Y   N   Y   Y   Y    Y   Y    Y   \+
  Shimomura et al. (2010) \[[@B40-nutrients-09-01047]\]       Y                 Y                N   N   N   N   Y    N   Y    N   --
  Waldron et al. (2017) \[[@B41-nutrients-09-01047]\]         Y                 Y                Y   N   Y   Y   Y    N   Y    Y   \+
  Total                                                       11                10               6   2   5   8   11   7   11   7   

Validity items: 1 research question stated; 2 subject selection free from bias; 3 comparable study groups; 4 method for withdrawals described; 5 blinding used; 6 interventions described; 7 outcomes stated, measurements valid and reliable; 8 appropriate statistical analysis; 9 appropriate conclusions, limitations described; 10 funding and sponsorship free from bias. Validity items 2, 3, 6, 7 must be satisfied for a positive quality rating. Y: yes, N: no, +: positive, ø: neutral, --: negative.

nutrients-09-01047-t004_Table 4

###### 

Rating of supplementation strategy and extent of muscle damage.

  References                                                  Extent of Muscle Damage   Supplementation Strategy          
  ----------------------------------------------------------- ------------------------- -------------------------- ------ ------
  Fouré et al. (2016) \[[@B32-nutrients-09-01047]\]           High                      Moderate                   Low    Low
  Ra et al. (2013) \[[@B39-nutrients-09-01047]\]              High                      Long                       High   Low
  Jackman et al. (2010) \[[@B36-nutrients-09-01047]\]         Moderate                  Short                      High   High
  Coombes & McNaughton (2000) \[[@B31-nutrients-09-01047]\]   Moderate                  Long                       High   High
  Howatson et al. (2012) \[[@B35-nutrients-09-01047]\]        Moderate                  Long                       High   High
  Greer et al. (2007) \[[@B34-nutrients-09-01047]\]           Low                       Short                      Low    Low
  Shimomura et al. (2010) \[[@B40-nutrients-09-01047]\]       Low                       Short                      Low    Low
  Gee & Deniel (2016) \[[@B33-nutrients-09-01047]\]           Low                       Short                      Low    High
  Matsumoto et al. (2007) \[[@B38-nutrients-09-01047]\]       Low                       Short                      High   High
  Waldron et al. (2017) \[[@B41-nutrients-09-01047]\]         Low                       Short                      High   High
  Kephart et al. (2016) \[[@B37-nutrients-09-01047]\]         Low                       Moderate                   Low    Low

nutrients-09-01047-t005_Table 5

###### 

Muscle damage exercise outcomes of included studies.

  References                                                  Effects in the Control Group                                                  Positive Effect of Supplementation
  ----------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------
  Muscle performance                                                                                                                        
  Fouré et al. (2016) \[[@B32-nutrients-09-01047]\]           Significant decrease in MVC from POST to D4                                   \-
  Gee & Deniel (2016) \[[@B33-nutrients-09-01047]\]           Significant decrease in CMJ and SSPT performances at D1                       Yes
  Greer et al. (2007) \[[@B34-nutrients-09-01047]\]           Significant decrease in torque (leg flexion and extension) from POST to D2    Yes
  Howatson et al. (2012) \[[@B35-nutrients-09-01047]\]        Significant decrease in MVC from D1 to D3                                     Yes
  Jackman et al. (2010) \[[@B36-nutrients-09-01047]\]         Significant decrease in maximal force from H1 to D3                           \-
  Kephart et al. (2016) \[[@B37-nutrients-09-01047]\]         Significant decrease in isokinetic peak torque                                \-
  Shimomura et al. (2010) \[[@B40-nutrients-09-01047]\]       Significant decrease in MVC at D3                                             Yes
  Waldron et al. (2017) \[[@B41-nutrients-09-01047]\]         Decrease in MVC and CMJ performance from POST to D1                           \-
  Blood analyses                                                                                                                            
  Coombes & McNaughton (2000) \[[@B31-nutrients-09-01047]\]   Significant increase in CK and LDH (from POST to D5)                          Yes
  Fouré et al. (2016) \[[@B32-nutrients-09-01047]\]           Significant increase in plasma CK activity at D3 and D4                       \-
  Greer et al. (2007) \[[@B34-nutrients-09-01047]\]           Significant increase in CK (from H4 to D2) and LDH (at H4)                    Yes
  Howatson et al. (2012) \[[@B35-nutrients-09-01047]\]        Significant increase in CK from D1 to D3                                      Yes
  Jackman et al. (2010) \[[@B36-nutrients-09-01047]\]         Significant increase in CK (from H8 to D3) and myoglobin (at H1, H8 and D3)   \-
  Kephart et al. (2016) \[[@B37-nutrients-09-01047]\]         Significant increase in myoglobin                                             \-
  Matsumoto et al. (2007) \[[@B38-nutrients-09-01047]\]       Significant increase in CK and LDH at POST                                    Yes
  Ra et al. (2013) \[[@B39-nutrients-09-01047]\]              Significant increase in CK and LDH at D3 and D4                               \-
  Shimomura et al. (2010) \[[@B40-nutrients-09-01047]\]       No significant change in CK and LDH on the three days post-exercise           \-
  Waldron et al. (2017) \[[@B41-nutrients-09-01047]\]         No change in CK on the two days post-exercise                                 \-

LDH: lactate dehydrogenase, CK: creatine kinase, POST: immediately after the damaging exercise, H: hour (e.g., H4: four hours after the end of the damaging exercise), D: day (e.g., D4: four days after the damaging exercise), MVC: maximal voluntary contraction force, CMJ: counter movement jump, SSPT: seated shot-put throw.
